Greenberg Traurig has advised private equity fund Gilde Healthcare on its acquisition of Acti-Med AG.
Financial details of the transaction were not disclosed.
According to Greenberg Traurig, “Gilde Healthcare is acquiring both Acti-Med AG, based in Hesse, and its wholly owned Polish subsidiary, based in Kozerki, by way of a share deal.”
Acti-Med focuses on the development and production of cannulas for the medical and pharmaceutical industries.
Greenberg Traurig’s team consisted of, in Berlin, Partners Henrik Armah, Viola Bensinger, and Martin Hamer, Local Partners Holger Faust, Konradin Pleul, Senior Associates Marco Stempin and Lucas Wusthof, Associates Lukas Gauert, Max Ruther, Philipp Barsch, Johanna Hofmann, Helena Muller, and Natalie Kopplow, and Transaction Lawyer Irina Kuznecova; and in Warsaw, Local Partner Filip Kijowski, Senior Associates Tomasz Denko and Anna Celejewska-Rajchert, and Associates Angelika Makar and Maxymilian Rybczynski.
The firm did not reply to an inquiry about the deal.